Neurology
Boston Biomedical Research Institute Licenses Immunotherapy Technology to Combat Alzheimer's Disease
The Boston Biomedical Research Institute (BBRI) has announced an agreement with Wyeth Pharmaceuticals to license its patented technology for immunotherapy to combat Alzheimer's disease. This collaboration builds on the work of senior scientist Vic Raso, whose research forms the basis for the patent applications. The deal aims to